Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway

Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway

Bibliographic Details
Main Author: Frontiers Editorial Office
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
KRAS mutation G12C
inhibitor 9
castration-resistant prostate cancer
drug resistance
metastasis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.707608/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.707608/full

Similar Items